Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9UPY3: Variant p.Gly1809Arg

Endoribonuclease Dicer
Gene: DICER1
Feedback?
Variant information Variant position: help 1809 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 1809 (G1809R, p.Gly1809Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PPB. Any additional useful information about the variant.


Sequence information Variant position: help 1809 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1922 The length of the canonical sequence.
Location on the sequence: help LRRSEEDEEKEEDIEVPKAM G DIFESLAGAIYMDSGMSLET The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LRRSEEDEEKEEDIEVPKAMGDIFESLAGAIYMDSGMSLET

Mouse                         LRRSEEDEEKEEDIEVPKAMGDIFESLAGAIYMDSGMSLEV

Bovine                        LRRSEEDEEKEEDIEVPKAMGDIFESLAGAIYMDSGMSLET

Chicken                       LRRSEEDEEKEEDIEVPKAMGDIFESLAGAIYMDSGMSLEM

Xenopus tropicalis            LRRSEEDEEKEEDIEVPKAMGDIFESLAGAIYMDSGMSLET

Zebrafish                     LRRSEEDEEKEEDIEVPKAMGDIFESLAGAIYMDSGMSLET
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1922 Endoribonuclease Dicer
Domain 1666 – 1824 RNase III 2
Binding site 1810 – 1810
Binding site 1813 – 1813
Site 1806 – 1806 Important for activity
Alternative sequence 1789 – 1922 LRRSEEDEEKEEDIEVPKAMGDIFESLAGAIYMDSGMSLETVWQVYYPMMRPLIEKFSANVPRSPVRELLEMEPETAKFSPAERTYDGKVRVTVEVVGKGKFKGVGRSYRIAKSAAARRALRSLKANQPQVPNS -> KSFLQMYPVPLCENCLKWNQKLPNLARLRELTTGRSESLWK. In isoform 2.
Mutagenesis 1813 – 1813 E -> A. Decreased activity. Loss of activity; when associated with E-1444.
Helix 1806 – 1822



Literature citations
Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model.
Brenneman M.; Field A.; Yang J.; Williams G.; Doros L.; Rossi C.; Schultz K.A.; Rosenberg A.; Ivanovich J.; Turner J.; Gordish-Dressman H.; Stewart D.; Yu W.; Harris A.; Schoettler P.; Goodfellow P.; Dehner L.; Messinger Y.; Hill D.A.;
F1000Research 4:214-214(2015)
Cited for: VARIANTS PPB LYS-1705; ASN-1709; ARG-1809; TYR-1810 AND GLN-1813;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.